271 related articles for article (PubMed ID: 16800728)
1. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):677-85. PubMed ID: 16800728
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
[TBL] [Abstract][Full Text] [Related]
3. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
[TBL] [Abstract][Full Text] [Related]
4. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
Hansen KK; Saifeddine M; Hollenberg MD
Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
[TBL] [Abstract][Full Text] [Related]
5. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
9. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
[TBL] [Abstract][Full Text] [Related]
10. Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.
Hollenberg MD; Saifeddine M; Al-Ani B; Gui Y
Can J Physiol Pharmacol; 1999 Jun; 77(6):458-64. PubMed ID: 10537233
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney.
Gui Y; Loutzenhiser R; Hollenberg MD
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F95-104. PubMed ID: 12644441
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
13. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
14. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
Ramachandran R; Hollenberg MD
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
Bunnett NW
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptors.
Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological actions of protease activated receptors (PARs).
Pandya NM; Jain SM; Santani DD
Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
[TBL] [Abstract][Full Text] [Related]
20. Thrombin induces DNA synthesis and phosphoinositide hydrolysis in airway smooth muscle by activation of distinct receptors.
Walker TR; Cadwallader KA; MacKinnon A; Chilvers ER
Biochem Pharmacol; 2005 Sep; 70(6):959-67. PubMed ID: 16026763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]